Skip to content

Investigation of improvement for the clinical condition of digestive tract diseases by fecal microbiota transplantation

Investigation of improvement for the clinical condition of digestive tract diseases by fecal microbiota transplantation - Fecal microbiota transplantation for the patients with ulcerative colitis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000022400
Enrollment
20
Registered
2016-05-21
Start date
2015-03-30
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ulcerative Colitis

Interventions

Fecal microbiota transplantation group

Sponsors

Chiba University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) The patient with mild or moderate UC. 2) Duration of UC is more than 3 years. 3) The UC patient has more than 2 donner candidates for microbiota

Exclusion criteria

Exclusion criteria: 1) The patient in intensive care units 2) The patient requires high doses of corticosteroid (1 mg/kg of body weight per day) 3) The patient who is treated with vasopressor 4) The patient who is unsutable to this study by the judgement of the attending physician

Design outcomes

Primary

MeasureTime frame
Alteration of Lichitiger Index at 8 weeks after fecal microbiota transplantation

Countries

Japan

Contacts

Public ContactTomoo Nakagawa

Chiba University Hospital Department of gastroenterology

tom20852@hospital.chiba-u.jp043-222-7171

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026